Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
Holding CYRX?
Track your performance easily
Earnings Data
Report Date
Mar 06, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.29Last Year’s EPS
-$1.31Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: -2.00%
|Next Earnings Date:Mar 06, 2025
Earnings Call Sentiment|Neutral
The earnings call revealed a balanced sentiment with growth in the Life Sciences Services segment and new contract acquisitions being offset by challenges in the MVE Products business and reduced biopharma funding. The company's cost reduction strategies and strong balance sheet provide a stable outlook despite current market challenges.Company Guidance
During the Cryoport Q3 2024 earnings call, the company provided guidance reflecting its expectation for the full-year revenue to range between $225 million and $235 million, maintaining this outlook despite the ongoing softness in the Life Sciences Product business. The Life Sciences Services business demonstrated robust performance, with a 9% growth in the third quarter and a notable improvement in gross margin to 46%. The company also highlighted milestones such as supporting 691 global clinical trials, an increase of 21 trials from the previous year, and executing cost reduction strategies expected to generate over $20 million in annualized savings. Despite challenges, Cryoport remains optimistic about achieving positive adjusted EBITDA during 2025, supported by its strategic focus on growth in the cell and gene therapy markets.Life Sciences Services Growth
Life Sciences Services business grew by 9% in the third quarter, with BioStorage and BioServices revenue increasing by over 12% compared to last year. Gross margin for the Life Science Services business improved to 46%.
Cryoport's IntegriCell Launch
Cryoport launched its IntegriCell cryopreservation solution with a new facility, providing standardized cryopreservation of leukapheresis material.
CRYOGENE Expansion
CRYOGENE successfully opened biorepository operations in San Antonio, Texas, and onboarded its first major client, a major cord blood repository.
CRYOPDP New Contracts
CRYOPDP was awarded 9 high-value contracts during the third quarter, with a total value of over $6 million per year.
Strong Balance Sheet
Cryoport maintains a strong balance sheet with over $270 million in cash and short-term investments.
---
CYRX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CYRX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $8.02 | $7.73 | -3.62% |
| Aug 06, 2024 | $7.79 | $7.77 | -0.26% |
| May 07, 2024 | $16.40 | $13.20 | -19.51% |
| Mar 12, 2024 | $16.30 | $14.36 | -11.90% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does CryoPort Inc (CYRX) report earnings?
CryoPort Inc (CYRX) is schdueled to report earning on Mar 06, 2025, TBA Not Confirmed.
What is CryoPort Inc (CYRX) earnings time?
CryoPort Inc (CYRX) earnings time is at Mar 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CYRX EPS forecast?
CYRX EPS forecast for the fiscal quarter 2024 (Q4) is -$0.29.
---